Meanwhile, through the Keap1-Nrf2-SOD pathway, T-MSCs can upregulate the expression of the antioxidant enzymes SOD-1 and SOD-2, and increase nuclear Nrf2 expression, thereby further enhancing the antioxidant capacity in PD. This evidence concerns the gene SOD2 and Parkinson disease.